Related Experiment Video
Updated: Jul 6, 2026

Sample Preparation for Metabolic Profiling using MALDI Mass Spectrometry Imaging
Published on: December 22, 2020
Plasma Lipidomics Profiling of Developmental Dysplasia of the Hip in Tibet Plateau
Xiaogang Li1, Jiamei Ji2, Ping Li3
1Biobank Facility, National Infrastructures for Translational Medicine, State Key Laboratory of Complex Severe and Rare Diseases Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College Beijing China.
Insights
Lipidomics analysis revealed distinct differences in plasma lipid profiles of infants with developmental dysplasia of the hip (DDH). Specific triacylglycerol (TAG) and phosphatidylethanolamine (PE) signatures may aid in DDH diagnosis.
Area of Science:
- Biochemistry
- Pediatric Medicine
- Metabolomics
Background:
- Developmental dysplasia of the hip (DDH) is a common pediatric condition with varied causes.
- Higher incidence rates of DDH are reported in populations on the Tibet plateau.
- This study investigated lipidomics profiles in relation to DDH.
Purpose of the Study:
- To identify specific lipidomics signatures associated with developmental dysplasia of the hip (DDH) in infants.
- To explore the potential of lipid profiles as diagnostic markers for DDH.
Main Methods:
- Plasma samples were collected from 50 infants (25 with DDH, 25 healthy controls).
- An untargeted lipidomics profiling approach was utilized.
- Comprehensive clinical data were gathered for each participant.
Main Results:
- Significant differences in lipidomics profiles were observed between DDH patients and controls.
- Key differential metabolites included various triacylglycerols (TAGs) and phosphatidylethanolamines (PEs).
- TAG(17:0/18:1/20:1) and TAG(17:0/17:0/17:0) were among the most significant altered lipids.
Conclusions:
- Infants with DDH exhibit distinct alterations in their plasma lipidomics profiles.
- This is the first study to report lipidomics signatures in DDH patients.
- Combined analysis of TAG(17:0/18:1/20:1) and TAG(17:0/17:0/17:0) shows potential as a diagnostic tool for DDH.
Background:
Developmental dysplasia of the hip (DDH) is a prevalent pediatric condition with a multifactorial etiology. Its incidence varies geographically, with notably higher rates observed on the Tibet plateau. This study was performed to evaluate the lipidomics signatures associated with DDH by analyzing plasma samples.
Methods:
Fifty infants were recruited, including 25 diagnosed with DDH and 25 age-matched healthy controls. In addition to plasma samples, comprehensive laboratory test results and medical records were collected for each participant. An untargeted lipidomics profiling approach was employed to identify distinguishing metabolic signatures.
Results:
Lipidomics profiles differed significantly between patients with DDH and healthy controls. Several differential metabolites were identified, including triacylglycerol (TAG)(17:0/18:1/20:1), TAG(17:0/17:0/17:0), phosphatidylethanolamine (PE)(10:0/26:4), TAG(17:0/18:0/18:0), TAG(16:0/17:0/22:1), TAG(16:0/18:0/22:0), TAG(17:0/19:0/19:0), TAG(13:0/20:0/20:0), TAG(18:0/18:0/22:0), and TAG(16:0/20:0/20:0). The primary lipid species showing differences were TAGs and PE.
Conclusions:
Distinct shifts in lipidomics profiles were observed in infants with DDH. To the best of our knowledge, this study is the first to explore lipidomics signatures in patients with DDH. The combined assessment of TAG(17:0/18:1/20:1) and TAG(17:0/17:0/17:0) may serve as a potential diagnostic tool for DDH.
More Related Videos
Related Concept Videos
Feedback Loops
Cell Specific Gene Expression
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Insulin: The Receptor and Signaling Pathways

